Literature DB >> 2183117

Changing concepts in the management of retinoblastoma.

J A Shields1, C L Shields, L A Donoso, W E Lieb.   

Abstract

For many years the most common treatment for retinoblastoma has been enucleation, generally performed on the affected eye in children with unilateral sporadic disease and on the more severely affected eye in children with bilateral disease. With refinements in conservative treatment methods, however, the affected eye now often may be salvaged and useful vision retained. Emphasizing this trend, we present our current approaches to managing retinoblastoma based on our experience with 324 patients, outlining our indications and pointing out a number of misconceptions about the role of enucleation, photocoagulation, cryotherapy, and radiotherapy in treating this condition. We also sketch some recent findings regarding the genetics of retinoblastoma and consider ways in which such research may lead to improved management of the disease.

Entities:  

Mesh:

Year:  1990        PMID: 2183117

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  4 in total

Review 1.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Quantification of lacrimal function after D-shaped field irradiation for retinoblastoma.

Authors:  S M Imhof; P Hofman; K E Tan
Journal:  Br J Ophthalmol       Date:  1993-08       Impact factor: 4.638

3.  Relationship of regression pattern to recurrence in retinoblastoma.

Authors:  A D Singh; D Garway-Heath; S Love; P N Plowman; J E Kingston; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1993-01       Impact factor: 4.638

4.  Orbital Pseudocellulitis: A Retinoblastoma-Associated Masquerade Syndrome.

Authors:  Francesco Martino; Maria Chiara Gelmi; Paolo Galluzzi; Sonia De Francesco; Clelia Miracco; Doris Hadjistilianou
Journal:  Ocul Oncol Pathol       Date:  2020-10-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.